Jagsonpal Pharma to acquire 85% stake in Aequitas Healthcare for ₹20.8 Cr

Jagsonpal Pharmaceuticals Ltd. has entered into a definitive agreement to acquire an 85% equity stake in Aequitas Healthcare Private Limited for ₹20.8 crores. This strategic acquisition marks Jagsonpal's entry into the hospital segment, aiming to strengthen its presence in India's healthcare ecosystem. Aequitas, founded in 2017, focuses on the sale and distribution of pharmaceutical products to hospitals and reported revenues of ₹53 crores in FY26. The transaction, funded by internal accruals, is expected to conclude by July 15, 2026. This move is seen as a transformative pivot for Jagsonpal, shifting from a legacy retail prescription player to an omnichannel specialty healthcare business.